TherapeuticsMD, Inc.·4

Nov 27, 5:05 PM ET

Milligan John C.K. IV 4

4 · TherapeuticsMD, Inc. · Filed Nov 27, 2020

Insider Transaction Report

Form 4
Period: 2020-11-24
Milligan John C.K. IV
DirectorPresident, Secretary, Director10% Owner
Transactions
  • Award

    Restricted Stock Units

    2020-11-24+360,000360,000 total
    Exercise: $0.00Common Stock (360,000 underlying)
Footnotes (1)
  • [F1]Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in two equal installments on November 24, 2021 and November 24, 2022.

Documents

1 file
  • 4
    ownership.xmlPrimary

    FORM 4 - MILLIGAN